Thyroid incidentalomas identified by18F-FDG PET: Sonographic correlation

American Journal of Roentgenology

Volumn 191, Issue 2, 2008, Pages 598-603

  Jin, Young Kwak ^a   Kim, Eun Kyung ^a   Yun, Mijin ^a   Cho, Arthur ^a   Min, Jung Kim ^a   Eun, Ju Son ^a   Ki, Keun Oh ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cancer; FDG PET; Fine needle aspiration biopsy; PET; Sonography; Thyroid incidentalomas

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RETROSPECTIVE STUDY; RISK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THYROID INCIDENTALOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; INCIDENTAL FINDING; MIDDLE AGED; NEEDLE BIOPSY; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING; STATISTICAL MODEL; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; LOGISTIC MODELS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 49149100877     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.3443     Document Type: Article

References (33)

1. Delbeke D. Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 1999; 40:591-603
2. Kao CH, Kwan AS, Kwan JK, Chow MJ. The role of 18F-fluorodeoxyglucose positron emission tomography in cancer screening: a preliminary report. Oncol Rep 2001; 8:1145-1148
3. Yasuda S, Ide M, Fujii H, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer 2000; 83:1607-1611
4. 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 2005; 25:1421-1426
5. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130:941-946
6. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003; 88:4100-4104
7. Yi JG, Marom EM, Munden RF, et al. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 2005; 236:271-275
8. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005; 115:1074-1078
9. 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 2006; 47:609-615
10. Ramos CD, Chisin R, Yeung HW, Larson SM, Macapinlac HA. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med 2001; 26:193-197
11. Davis PW, Perrier ND, Adler L, Levine EA. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg 2001; 67:582-584
12. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med 2006; 47:770-775
13. Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose: whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 2002; 87:1517-1520
14. Are C, Hsu JF, Schoder H, Shah JP, Larson SM, Shaha AR. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol 2007; 14:239-247
15. Gordon BA, Flanagan FL, Dehdashti F. Wholebody positron emission tomography: normal variations, pitfalls, and technical considerations. AJR 1997; 169:1675-1680
16. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. RadioGraphics 1999; 19:61-77; quiz 150-151
17. Khoo ML, Asa SL, Witterick IJ, Freeman JL. Thyroid calcification and its association with thyroid carcinoma. Head Neck 2002; 24:651-655
18. Kim EK, Park CS, Chung WY, et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR 2002; 178:687-691
19. Peccin S, de Castsro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA. Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules? J Endocrinol Invest 2002; 25:39-43
20. Chan BK, Desser TS, McDougall IR, Weigel RJ, Jeffrey RB Jr. Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med 2003; 22:1083-1090
21. Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med 2003; 22:127-131; quiz 132-124
22. Cappelli C, Castellano M, Pirola I, et al. The predictive value of ultrasound findings in the management of thyroid nodules. QJM 2007; 100:29-35
23. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328:553-559
24. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154:1838-1840
25. Clark KJ, Cronan JJ, Scola FH. Color Doppler sonography: anatomic and physiologic assessment of the thyroid. J Clin Ultrasound 1995; 23:215-223
26. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955; 15:1270-1280
27. Mitchell J, Parangi S. The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MR 2005; 26:37-46
28. 18FDG-PET/CT. Surgery 2005; 138:1166-1174; discussion 1174-1175
29. Tae HJ, Lim DJ, Baek KH, et al. Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid 2007; 17:461-466
30. Lin JD, Huang BY, Weng HF, Jeng LB, Hsueh C. Thyroid ultrasonography with fine-needle aspiration cytology for the diagnosis of thyroid cancer. J Clin Ultrasound 1997; 25:111-118
31. Amrikachi M, Ramzy I, Rubenfeld S, Wheeler TM. Accuracy of fine-needle aspiration of thyroid. Arch Pathol Lab Med 2001; 125:484-488
32. Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer 1989; 63:718-725
33. Nam SY, Roh JL, Kim JS, Lee JH, Choi SH, Kim SY. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin Endocrinol (Oxf) 2007; 67:135-139